FindTrial
Sign In

The effectiveness of intraoperative blood salvage in enhanced recovery after total hip arthroplasty under modern blood management

The effectiveness of intraoperative blood salvage in enhanced recovery after total hip arthroplasty under modern blood management

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ORC-16010057
Enrollment
Unknown
Registered
2016-12-02
Start date
2016-11-30
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

osteolysis, aseptic loosening, and periprosthetic fracture or malposition

Interventions

experimental group:Patients were transfused autologous blood intraoperatively
control group:Patients were not transfused autologous blood intraoperatively

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 83 Years

Inclusion criteria

Inclusion criteria: Patients who were scheduled for revision THA for osteolysis, aseptic loosening, and periprosthetic fracture or malposition were considered eligible for inclusion in the trial.

Exclusion criteria

Exclusion criteria: Patients on the presence of current infection and dysfunction of blood coagulation, patients with a history of hemophilia, pulmonary embolism or ischemic heart disease.

Design outcomes

Primary

MeasureTime frame
Allogenic transfusion units and rate;intraoperative blood loss and postoperative drainage volume. ;—

Secondary

MeasureTime frame
HB and HCT drop;postoperative hospital stay;—

Countries

China

Contacts

Public ContactFuxing Pei

West China Hospital, Sichuan University

peifuxinghuaxi@163.com+86 18980601380

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026